Loss of an Immunodominant HLA-A *01:01 Restricted Epitope for CD8+ Cytotoxic T Lymphocytes (CTLs) in the Delta Variant of COVID-19: An Example of Immunologic Escape and Implications for Immunologic Treatment

November 23, 2021

TVGN-489: A novel approach for the production of SARS-CoV-2-specific cytotoxic T lymphocytes to treat COVID-19

May 1, 2021

About Us
Get in Touch

New Jersey, USA

© 2023 Tevogen Bio. All Rights Reserved.